['condylomata acuminata', 'papillomavirus infections', 'sexually transmitted diseases']
['ranpirnase', 'vehicle']

        Inclusion Criteria:

          -  Diagnosis of external genital / perianal warts with at least 2 warts and no more than
             30 lesions

          -  Accept to follow study instructions / signature of IC

          -  Abstain from sexual intercourse for 6 hours after applying the study product during
             the time of the study.

        Exclusion Criteria:

          -  Any topical and/or destructive treatments for external genital warts within 4 weeks
             (within 12 months for imiquimod and within 12 weeks for sinecatechins) prior to
             enrollment (i.e., the randomization visit)

          -  Non pregnant. For women in reproductive age it would be required pregnancy test, and
             the use of double barrier contraceptives.

          -  Any of the following conditions:

          -  Known allergy to the study product

          -  Internal (rectal, urethral) warts that required or were undergoing treatment;

          -  A dermatological disease (e.g., psoriasis) or skin condition in the area, which may
             interfere with the evaluation.

          -  Imiquimod 5% cream (Aldara®)

          -  Any marketed or investigational HPV vaccines

          -  Sinecatechins (Veregen)

          -  Interferon or interferon inducers

          -  Cytotoxic drugs

          -  Immunomodulators or immunosuppressives

          -  Oral or parenteral corticosteroids (inhaled/intranasal steroids are permitted)

          -  Oral antiviral drugs (with the exception of HAART, oral acyclovir and acyclovir
             related drugs) for suppressive or acute therapy herpes; or oseltamivir for prophylaxis
             or for influenza)

          -  Topical antiviral drugs (including topical acyclovir and acyclovir related drugs) in
             the areas under treatment

          -  Podophyllotoxin/Podofilox in the treatment areas

          -  Any topical prescription medications in the treatment areas

          -  Dermatologic procedures or surgery in the treatment areas
      